X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10061) 10061
Book Chapter (93) 93
Publication (9) 9
Dissertation (6) 6
Magazine Article (6) 6
Conference Proceeding (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
monotherapy (7201) 7201
humans (6791) 6791
male (4090) 4090
female (3844) 3844
middle aged (3149) 3149
adult (2771) 2771
treatment outcome (2404) 2404
aged (2269) 2269
double-blind (1978) 1978
efficacy (1831) 1831
pharmacology & pharmacy (1631) 1631
therapy (1503) 1503
drug therapy, combination (1417) 1417
clinical neurology (1388) 1388
oncology (1331) 1331
adolescent (1076) 1076
safety (1058) 1058
epilepsy (1036) 1036
drug therapy (1012) 1012
psychiatry (945) 945
care and treatment (876) 876
anticonvulsants - therapeutic use (823) 823
combination therapy (815) 815
retrospective studies (801) 801
analysis (793) 793
trial (768) 768
aged, 80 and over (756) 756
double-blind method (746) 746
medicine, general & internal (717) 717
combination (696) 696
epilepsy - drug therapy (690) 690
infectious diseases (689) 689
clinical trials (677) 677
child (676) 676
cancer (629) 629
young adult (627) 627
antiepileptic drugs (626) 626
carbamazepine (625) 625
medicine & public health (615) 615
management (610) 610
diabetes mellitus, type 2 - drug therapy (595) 595
dose-response relationship, drug (586) 586
follow-up studies (583) 583
time factors (574) 574
prospective studies (573) 573
patients (565) 565
research (564) 564
endocrinology & metabolism (562) 562
risk factors (556) 556
chemotherapy (550) 550
multicenter (548) 548
children (547) 547
immunology (547) 547
health aspects (508) 508
drug administration schedule (507) 507
lamotrigine (500) 500
anticonvulsants - adverse effects (499) 499
randomized controlled trials as topic (496) 496
neurosciences (493) 493
type 2 diabetes (491) 491
surgery (470) 470
open-label (448) 448
pharmacokinetics (442) 442
metformin (432) 432
transplantation (431) 431
seizures (425) 425
gastroenterology & hepatology (422) 422
animals (419) 419
dosage and administration (418) 418
diabetes (417) 417
bipolar disorder (406) 406
hypoglycemic agents - therapeutic use (401) 401
rheumatology (385) 385
mortality (380) 380
risk (377) 377
neurology (374) 374
tolerability (371) 371
bipolar disorder - drug therapy (368) 368
rheumatoid arthritis (366) 366
abridged index medicus (364) 364
internal medicine (363) 363
hypertension (361) 361
child, preschool (355) 355
placebo (355) 355
medical research (354) 354
urology & nephrology (352) 352
prostate cancer (348) 348
studies (348) 348
anticonvulsants (345) 345
survival (339) 339
microbiology (336) 336
pediatrics (331) 331
severity of illness index (329) 329
hematology (327) 327
medicine, research & experimental (326) 326
metaanalysis (318) 318
glycemic control (314) 314
quality of life (313) 313
drugs (301) 301
prognosis (300) 300
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9471) 9471
German (208) 208
Spanish (168) 168
French (121) 121
Russian (76) 76
Japanese (65) 65
Italian (38) 38
Polish (18) 18
Turkish (16) 16
Czech (11) 11
Portuguese (10) 10
Hungarian (9) 9
Korean (8) 8
Chinese (3) 3
Slovak (2) 2
Hebrew (1) 1
Indonesian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 2018, Volume 36, Issue 4, pp. 391 - 398
Purpose The clinical activity observed in a phase I dose-escalation study of concurrent therapy with nivolumab (NIVO) and ipilimumab (IPI) in patients with... 
UNTREATED MELANOMA | DABRAFENIB | PEMBROLIZUMAB | MONOTHERAPY | ONCOLOGY | TRAMETINIB | Original Reports
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0171611
Objective The primary objective of this study was to estimate the incidence of treatment failure (TF) to protease inhibitor monotherapies (Pl/r-MT) with... 
GLOMERULAR-FILTRATION-RATE | REVERSE-TRANSCRIPTASE INHIBITORS | EFFECTIVE ANTIRETROVIRAL THERAPY | MYOCARDIAL-INFARCTION | MULTIDISCIPLINARY SCIENCES | PROTEASE INHIBITOR MONOTHERAPY | LOPINAVIR-RITONAVIR MONOTHERAPY | INCOMPLETE REVERSIBILITY | MONET TRIAL | HIV-1-INFECTED PATIENTS | COHORT COLLABORATION | Outcome Assessment (Health Care) - methods | Humans | Middle Aged | Male | HIV - drug effects | Viral Load | Young Adult | RNA, Viral - genetics | Ritonavir - therapeutic use | Adult | Female | Antiretroviral Therapy, Highly Active - methods | Drug Therapy, Combination | HIV Infections - virology | Kaplan-Meier Estimate | Proportional Hazards Models | Viremia - genetics | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | Outcome Assessment (Health Care) - statistics & numerical data | HIV - genetics | HIV Infections - drug therapy | Lopinavir - therapeutic use | Viremia - blood | Darunavir - therapeutic use | Cohort Studies | Antiviral agents | RNA | Ritonavir | Analysis | Dosage and administration | Research | HIV infection | Antiretroviral drugs | Therapy | Viremia | Lopinavir | Regression analysis | Criteria | Ribonucleic acid--RNA | Medical diagnosis | Patients | Reintroduction | CD4 antigen | Studies | Infectious diseases | Databases | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Hemoglobin | Data collection | Drug therapy | Failure | Deoxyribonucleic acid--DNA | Acquired immune deficiency syndrome | Deoxyribonucleic acid | Ribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Epilepsia (Copenhagen), ISSN 0013-9580, 2013, Volume 54, Issue 3, pp. 551 - 563
Journal Article
Journal Article